Top Markets
#1 Seeker Seeker +17.63%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.48%
#4 aelf aelf +6.19%
#5 Solstice Solstice +5.55%
#6 Official Trump Official Trump +4.71%
#7 Derive Derive +4.46%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +4.18%
#9 Arowana Arowana +3.74%
#10 DexNet DexNet +3.67%
Coin of the day
Seeker Seeker
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Clasificación en acciones #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye, its corporate operations are based in Boston, Massachusetts.
Precio por acción
$30.90
Última sincronización: 2026-08-27
Capitalización bursátil
$1.90B
Cambio (1 día)
1.68%
Cambio (1 año)
859.63%
País
US
Comercio Damora Therapeutics, Inc. (DMRA)

Categoría

Healthcare
Ratio P/B de Damora Therapeutics, Inc. (DMRA)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Damora Therapeutics, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Damora Therapeutics, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH